• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

8
1

CATEGORIES

  • 62
  • 19
  • 16
  • 9
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

24
27
110
122

PUBLISHED

5
16
34
122

PRODUCT TYPE

83
38
1

Search "Neuropathy Therapy Area Pipeline Report" returned 122 results.

PRODUCT TITLE
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

April 2015
FROM
Peripheral Neuropathy and Neuropathic Pain 2008 Peripheral Neuropathy and Neuropathic Pain 2008 - Product Thumbnail Image

Peripheral Neuropathy and Neuropathic Pain 2008

This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally PN and NP are causally linked to a number of diseases, however diabetes,...

June 2009
FROM

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth

“Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth” provides in-depth analysis of the, drivers and...

September 2011
FROM
Nitric Oxide - Therapeutics, Markets and Companies Nitric Oxide - Therapeutics, Markets and Companies - Product Thumbnail Image

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

April 2015
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

January 2015
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014’, provides an overview of the Peripheral...

August 2014
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2014’, provides an overview...

March 2014
FROM
The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007 The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007 - Product Thumbnail Image

The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007

With a market size of US$14 5 billion in 2005 and an anticipated value of US$16 5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech...

January 2007
FROM
The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide - Product Thumbnail Image

The Top 50 Developers Of Pain Management Pharmaceuticals Worldwide

Did you know? - Since NAPP Pharmaceuticals Limited launched their first product in the field of pain, they have expanded their portfolio to include six medicines in 15 different formulations, each in...

May 2012
FROM

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Peripheral Neuropathy’s therapeutic...

January 2015
FROM

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2014

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2014’, provides an overview of the Diabetic Peripheral...

May 2014
FROM

Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease

GBI Research’s report “Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for...

May 2013
FROM

Optic Neuropathy - Pipeline Review, H1 2015

Optic Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Optic Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Optic Neuropathy’s therapeutic pipeline. This report provides...

January 2015
FROM

Optic Neuropathy - Pipeline Review, H2 2014

Optic Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Optic Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Optic Neuropathy’s therapeutic pipeline. This report provides...

December 2014
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy...

December 2014
FROM
Pain Therapeutics - Drugs, Markets and Companies Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

April 2015
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy...

February 2015
FROM

Diabetic Neuropathy - Pipeline Review, H1 2014

Diabetic Neuropathy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H1 2014’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This...

March 2014
FROM

Diabetic Neuropathy - Pipeline Review, H2 2014

Diabetic Neuropathy - Pipeline Review, H2 2014 Summary This, ‘Diabetic Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report...

August 2014
FROM
Genethon - Product Pipeline Review - 2012 Genethon - Product Pipeline Review - 2012 - Product Thumbnail Image

Genethon - Product Pipeline Review - 2012

Genethon – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Genethon - Product Pipeline Review - 2012” provides data on the Genethon’s research and development...

October 2012
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office